Uncategorized

Lilly bets $3B+ to add China’s Haisco to growing list of partners in five-program pact

Published

on

Eli Lilly and the Haisco Pharmaceutical Group have yet to disclose what specific indications they plan to prioritize.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version